These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8104882)

  • 41. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles.
    Layton GT; Harris SJ; Gearing AJ; Hill-Perkins M; Cole JS; Griffiths JC; Burns NR; Kingsman AJ; Adams SE
    J Immunol; 1993 Jul; 151(2):1097-107. PubMed ID: 8335892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responses.
    Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Chibbar R; Wei Y; Liu Q; Xiang J
    Vaccine; 2011 Apr; 29(19):3538-47. PubMed ID: 21406265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus.
    Michel F; Hoffenbach A; Langlade-Demoyen P; Guy B; Girard M; Lecocq JP; Wain-Hobson S; Kieny MP; Plata F
    Eur J Immunol; 1988 Dec; 18(12):1917-24. PubMed ID: 2905993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes.
    Fujimoto C; Nakagawa Y; Ohara K; Takahashi H
    Int Immunol; 2004 Jan; 16(1):55-63. PubMed ID: 14688061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo.
    Raychaudhuri S; Tonks M; Carbone F; Ryskamp T; Morrow WJ; Hanna N
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8308-12. PubMed ID: 1518862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine.
    Huang W; Nardelli B; Tam JP
    Mol Immunol; 1994 Oct; 31(15):1191-9. PubMed ID: 7935506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity.
    Defoort JP; Nardelli B; Huang W; Tam JP
    Int J Pept Protein Res; 1992; 40(3-4):214-21. PubMed ID: 1478779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macromolecular assemblage in the design of a synthetic AIDS vaccine.
    Defoort JP; Nardelli B; Huang W; Ho DD; Tam JP
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3879-83. PubMed ID: 1349173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses.
    Nardelli B; Haser PB; Tam JP
    Vaccine; 1994 Nov; 12(14):1335-9. PubMed ID: 7856301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of fixed autologous stimulator cells to correctly present human immunodeficiency virus type 1 viral peptides to nonhuman primate lymphocytes in proliferation and cytotoxic T-lymphocyte assays.
    Munroe KJ; Anderson CA; Wu JY; Wyand MS; Newman GW; Newman MJ
    Clin Diagn Lab Immunol; 1994 May; 1(3):283-9. PubMed ID: 7496963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Yeast retrotransposon particles as antigen delivery systems.
    Kingsman AJ; Burns NR; Layton GT; Adams SE
    Ann N Y Acad Sci; 1995 May; 754():202-13. PubMed ID: 7625653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
    Moore A; McGuirk P; Adams S; Jones WC; McGee JP; O'Hagan DT; Mills KH
    Vaccine; 1995 Dec; 13(18):1741-9. PubMed ID: 8701587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo induction of CD4+ T cell responses by antigens covalently linked to synthetic microspheres does not require adjuvant.
    Gengoux C; Leclerc C
    Int Immunol; 1995 Jan; 7(1):45-53. PubMed ID: 7718515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pimelautide or trimexautide as built-in adjuvants associated with an HIV-1-derived peptide: synthesis and in vivo induction of antibody and virus-specific cytotoxic T-lymphocyte-mediated response.
    Déprez B; Gras-Masse H; Martinon F; Gomard E; Lévy JP; Tartar A
    J Med Chem; 1995 Feb; 38(3):459-65. PubMed ID: 7853339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen.
    White WI; Cassatt DR; Madsen J; Burke SJ; Woods RM; Wassef NM; Alving CR; Koenig S
    Vaccine; 1995 Aug; 13(12):1111-22. PubMed ID: 7491819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL.
    Deprez B; Sauzet JP; Boutillon C; Martinon F; Tartar A; Sergheraert C; Guillet JG; Gomard E; Gras-Masse H
    Vaccine; 1996 Apr; 14(5):375-82. PubMed ID: 8735547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells.
    Nair S; Babu JS; Dunham RG; Kanda P; Burke RL; Rouse BT
    J Virol; 1993 Jul; 67(7):4062-9. PubMed ID: 8510217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.
    Smith PM; Zhang Y; Jennings SR; O'Callaghan DJ
    J Virol; 1998 Jul; 72(7):5366-72. PubMed ID: 9620990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytotoxic T lymphocyte activation by cross-priming.
    Heath WR; Carbone FR
    Curr Opin Immunol; 1999 Jun; 11(3):314-8. PubMed ID: 10375548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.